Updating results

Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115)

This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.

NICE guideline Published December 2018 Last updated July 2019

Panic disorder

Everything NICE has said on diagnosing and managing panic disorder in adults in an interactive flowchart

NICE Pathway Published March 2012 Last updated July 2019

End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61)

This guideline covers the planning and management of end of life and palliative care in for infants, children and young people (aged 0–17 years) with life-limiting conditions. It aims to involve children, young people and their families in decisions about their care, and improve the support that is available to them throughout their lives.

NICE guideline Published December 2016 Last updated July 2019

Urinary incontinence and pelvic organ prolapse in women

Everything NICE has said about managing urinary incontinence and pelvic organ prolapse in women in an interactive flowchart

NICE Pathway Published September 2013 Last updated July 2019

Nusinersen for treating spinal muscular atrophy (TA588)

Evidence-based recommendations on nusinersen (Spinraza) for treating spinal muscular atrophy in children and adults

Technology appraisal guidance Published July 2019

Transurethral laser ablation for recurrent non-muscle-invasive bladder cancer (IPG656)

Evidence-based recommendations on transurethral laser ablation for recurrent non-muscle-invasive bladder cancer in adults

Interventional procedures guidance Published July 2019

Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids (IPG657)

Evidence-based recommendations on ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids in adults

Interventional procedures guidance Published July 2019

Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activity (TA589)

Evidence-based recommendations on blinatumomab (Blincyto) for treating Philadelphia-chromosome-negative CD19-positive B-precursor acute lymphoblastic leukaemia

Technology appraisal guidance Published July 2019

Hypertension in pregnancy

Everything NICE has said on diagnosing and managing hypertension in pregnancy in an interactive flowchart

NICE Pathway Published August 2013 Last updated July 2019

Heavy menstrual bleeding

Everything NICE has said on assessing and managing heavy menstrual bleeding in an interactive flowchart

NICE Pathway Published February 2012 Last updated July 2019

Bladder cancer

Everything NICE has said on bladder cancer in adults in an interactive flowchart

NICE Pathway Published December 2015 Last updated July 2019

Care and support of people growing older with learning disabilities

Everything NICE has said on the care and support of people growing older with learning disabilities

NICE Pathway Published April 2018 Last updated July 2019

Motor neurone disease: assessment and management (NG42)

This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.

NICE guideline Published February 2016 Last updated July 2019

Neuropathic pain

Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart

NICE Pathway Published November 2013 Last updated July 2019

Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173)

This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living. The guideline sets out how drug treatments for neuropathic pain differ from traditional pain management.

Clinical guideline Published November 2013 Last updated July 2019

Sarcoma

Everything NICE has said on sarcoma in an interactive flowchart

NICE Pathway Published January 2015 Last updated July 2019

Acute upper gastrointestinal bleeding

Everything NICE has said on risk assessment and management of acute upper gastrointestinal bleeding in people 16 years and older in an interactive flowchart

NICE Pathway Published June 2012 Last updated July 2019

Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (DG36)

Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis

Diagnostics guidance Published July 2019

Lyme disease

Everything NICE has said on diagnosing and managing Lyme disease in an interactive flowchart

NICE Pathway Published April 2018 Last updated July 2019

Hearing loss

Everything NICE has said on hearing loss or impairment in adults in an interactive flowchart

NICE Pathway Published June 2018 Last updated July 2019

Bisphosphonates for treating osteoporosis (TA464)

Evidence-based recommendations on bisphosphonates (alendronic acid; ibandronic acid; risedronate sodium; zoledronic acid) for treating osteoporosis in adults

Technology appraisal guidance Published August 2017 Last updated July 2019

Suspected neurological conditions: recognition and referral (NG127)

This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.

NICE guideline Published May 2019 Last updated July 2019

Child abuse and neglect

Everything NICE has said on child abuse and neglect in an interactive flowchart

NICE Pathway Published October 2017 Last updated July 2019

Contraception

Everything NICE has said on contraceptive services, long-acting reversible contraception and sterilisation in an interactive flowchart

NICE Pathway Published March 2014 Last updated July 2019

Contraceptive services for under 25s

Everything NICE has said on contraceptive services for under 25s in an interactive flowchart

NICE Pathway Published March 2014 Last updated July 2019

Long-acting reversible contraception (CG30)

This guideline covers long-acting reversible contraception. It aims to increase the use of long-action reversible contraception by improving the information given to women about their contraceptive choices.

Clinical guideline Published October 2005 Last updated July 2019

Dementia

Everything NICE has said on assessment, management and support for people living with dementia and Alzheimer's disease and their carers in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Lenalidomide plus dexamethasone for previously untreated multiple myeloma (TA587)

Evidence-based recommendations on lenalidomide (Revlimid) plus dexamethasone for previously untreated multiple myeloma in adults

Technology appraisal guidance Published June 2019

Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib (TA586)

Evidence-based recommendations on lenalidomide (Revlimid) plus dexamethasone for multiple myeloma after 1 treatment with bortezomib in adults

Technology appraisal guidance Published June 2019

Cardiac contractility modulation device implantation for heart failure (IPG655)

Evidence-based recommendations on cardiac contractility modulation device implantation for heart failure in adults

Interventional procedures guidance Published June 2019

Reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia (IPG654)

Evidence-based recommendations on reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia

Interventional procedures guidance Published June 2019

Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction (IPG653)

Evidence-based recommendations on valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) for aortic bioprosthetic valve dysfunction in adults

Interventional procedures guidance Published June 2019

Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality (TA322)

Evidence-based recommendations on lenalidomide (Revlimid) for myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality

Technology appraisal guidance Published September 2014 Last updated June 2019

Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies (TA171)

Evidence-based recommendations on lenalidomide (Revlimid) for the treatment of multiple myeloma in people who have received at least 2 prior therapies

Technology appraisal guidance Published June 2009 Last updated June 2019

Faecal incontinence

Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart

NICE Pathway Published February 2013 Last updated June 2019

Structural heart defects

Everything NICE has said on structural heart defects in an interactive flowchart

NICE Pathway Published November 2013 Last updated June 2019

Hypertension in pregnancy: diagnosis and management (NG133)

This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension. It aims to improve care during pregnancy, labour and birth for women and their babies.

NICE guideline Published June 2019

Depression in children and young people: identification and management (NG134)

This guideline covers identifying and managing depression in children and young people aged 5 to 18 years. Based on the stepped-care model, it aims to improve recognition and assessment and promote effective treatments for mild and moderate to severe depression.

NICE guideline Published June 2019

Antisocial behaviour and conduct disorders in children and young people

Everything NICE has said on antisocial behaviour and conduct disorders in children and young people in an interactive flowchart

NICE Pathway Published March 2013 Last updated June 2019

Diabetes in pregnancy

Everything NICE has said on managing diabetes and its complications before, during and after pregnancy in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Autism spectrum disorder

Everything NICE has said on recognition, referral, diagnosis and management of autism in an interactive flowchart

NICE Pathway Published June 2012 Last updated June 2019

Obsessive-compulsive disorder and body dysmorphic disorder

Everything NICE has said on treating obsessive-compulsive disorder and body dysmorphic disorder in an interactive flowchart

NICE Pathway Published June 2012 Last updated June 2019

Attachment difficulties in children and young people

Everything NICE has said on identifying, assessing and treating attachment disorders in under 18s in an interactive flowchart

NICE Pathway Published November 2015 Last updated June 2019

Depression in children and young people

Everything NICE has said on identifying, treating and managing depression in children and young people in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Urinary incontinence and pelvic organ prolapse in women: management (NG123)

This guideline covers assessing and managing urinary incontinence and pelvic organ prolapse in women aged 18 and over. It also covers complications associated with mesh surgery for these conditions.

NICE guideline Published April 2019 Last updated June 2019

What is the most effective surgical management for women with both stress urinary incontinence and pelvic organ prolapse, including the sequence of interventions?

Recommendation ID NG123/7 Question What is the most effective surgical management for women with both stress urinary incontinence and pelvic

Research recommendation Published June 2019

What is the effectiveness and cost effectiveness of stereotactic ablative radiotherapy (SABR) compared with surgery (for example, sublobar, wedge resection, lobectomy) for people with non-small-cell lung cancer (stage I and IIA) in whom surgery is suitable?

Recommendation ID NG122/2 Question What is the effectiveness and cost effectiveness of stereotactic ablative radiotherapy (SABR) compared

Research recommendation Published June 2019

What is the effectiveness and cost effectiveness of routinely performing contrast-enhanced brain CT at the time of initial diagnosis and/or staging CT?

Recommendation ID NG122/3 Question What is the effectiveness and cost effectiveness of routinely performing contrast-enhanced brain CT at

Research recommendation Published June 2019

What is the effectiveness and cost effectiveness of prophylactic cranial irradiation compared with routine MRI follow-up in people with extensive-stage small-cell lung cancer without brain metastases?

Recommendation ID NG122/4 Question What is the effectiveness and cost effectiveness of prophylactic cranial irradiation compared with routine

Research recommendation Published June 2019

What are the long-term outcomes, including patient satisfaction, from the use of pessaries compared with surgery for pelvic organ prolapse in women?

Recommendation ID NG123/4 Question What are the long-term outcomes, including patient satisfaction, from the use of pessaries compared with

Research recommendation Published June 2019